- call +1-201-465-4211
- email sales@mrinsights.biz
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Glycated albumin industry is relatively concentrated, manufacturers are mostly in the Europe, North America, Japan and China. Among them, Japan output value accounted for more than 81.90% of the total output value of global glycated albumin. Asahi Kasei Pharma is the world leading manufacturer in global glycated albumin market with the market share of 79.81% in 2015, in terms of revenue.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality.
The average price of glycated albumin will fall further. The product average price declined in the past few years due to the technology development, the average price will keep this trend in the few future years due to increasing mature manufacturing technology and cost of raw materials.
According to this study, over the next five years the Glycated Albumin market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 490 million by 2024, from US$ 340 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Glycated Albumin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Glycated Albumin market by product type, application, key manufacturers and key regions and countries.
This study considers the Glycated Albumin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Glycated Albumin (Human)
Glycated Albumin (Animal)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals and Clinics
Laboratories
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Glycated Albumin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Glycated Albumin market by identifying its various subsegments.
Focuses on the key global Glycated Albumin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Glycated Albumin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Glycated Albumin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Glycated Albumin Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glycated Albumin Consumption 2014-2024
2.1.2 Glycated Albumin Consumption CAGR by Region
2.2 Glycated Albumin Segment by Type
2.2.1 Glycated Albumin (Human)
2.2.2 Glycated Albumin (Animal)
2.3 Glycated Albumin Consumption by Type
2.3.1 Global Glycated Albumin Consumption Market Share by Type (2014-2019)
2.3.2 Global Glycated Albumin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Glycated Albumin Sale Price by Type (2014-2019)
2.4 Glycated Albumin Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Laboratories
2.5 Glycated Albumin Consumption by Application
2.5.1 Global Glycated Albumin Consumption Market Share by Application (2014-2019)
2.5.2 Global Glycated Albumin Value and Market Share by Application (2014-2019)
2.5.3 Global Glycated Albumin Sale Price by Application (2014-2019)
3 Global Glycated Albumin by Players
3.1 Global Glycated Albumin Sales Market Share by Players
3.1.1 Global Glycated Albumin Sales by Players (2017-2019)
3.1.2 Global Glycated Albumin Sales Market Share by Players (2017-2019)
3.2 Global Glycated Albumin Revenue Market Share by Players
3.2.1 Global Glycated Albumin Revenue by Players (2017-2019)
3.2.2 Global Glycated Albumin Revenue Market Share by Players (2017-2019)
3.3 Global Glycated Albumin Sale Price by Players
3.4 Global Glycated Albumin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Glycated Albumin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Glycated Albumin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Glycated Albumin by Regions
4.1 Glycated Albumin by Regions
4.1.1 Global Glycated Albumin Consumption by Regions
4.1.2 Global Glycated Albumin Value by Regions
4.2 Americas Glycated Albumin Consumption Growth
4.3 APAC Glycated Albumin Consumption Growth
4.4 Europe Glycated Albumin Consumption Growth
4.5 Middle East & Africa Glycated Albumin Consumption Growth
5 Americas
5.1 Americas Glycated Albumin Consumption by Countries
5.1.1 Americas Glycated Albumin Consumption by Countries (2014-2019)
5.1.2 Americas Glycated Albumin Value by Countries (2014-2019)
5.2 Americas Glycated Albumin Consumption by Type
5.3 Americas Glycated Albumin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Glycated Albumin Consumption by Countries
6.1.1 APAC Glycated Albumin Consumption by Countries (2014-2019)
6.1.2 APAC Glycated Albumin Value by Countries (2014-2019)
6.2 APAC Glycated Albumin Consumption by Type
6.3 APAC Glycated Albumin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Glycated Albumin by Countries
7.1.1 Europe Glycated Albumin Consumption by Countries (2014-2019)
7.1.2 Europe Glycated Albumin Value by Countries (2014-2019)
7.2 Europe Glycated Albumin Consumption by Type
7.3 Europe Glycated Albumin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Glycated Albumin by Countries
8.1.1 Middle East & Africa Glycated Albumin Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Glycated Albumin Value by Countries (2014-2019)
8.2 Middle East & Africa Glycated Albumin Consumption by Type
8.3 Middle East & Africa Glycated Albumin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Glycated Albumin Distributors
10.3 Glycated Albumin Customer
11 Global Glycated Albumin Market Forecast
11.1 Global Glycated Albumin Consumption Forecast (2019-2024)
11.2 Global Glycated Albumin Forecast by Regions
11.2.1 Global Glycated Albumin Forecast by Regions (2019-2024)
11.2.2 Global Glycated Albumin Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Glycated Albumin Forecast by Type
11.8 Global Glycated Albumin Forecast by Application
12 Key Players Analysis
12.1 Asahi Kasei Pharma
12.1.1 Company Details
12.1.2 Glycated Albumin Product Offered
12.1.3 Asahi Kasei Pharma Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Asahi Kasei Pharma News
12.2 DIAZYME
12.2.1 Company Details
12.2.2 Glycated Albumin Product Offered
12.2.3 DIAZYME Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 DIAZYME News
12.3 Abnova
12.3.1 Company Details
12.3.2 Glycated Albumin Product Offered
12.3.3 Abnova Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Abnova News
12.4 LifeSpan
12.4.1 Company Details
12.4.2 Glycated Albumin Product Offered
12.4.3 LifeSpan Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 LifeSpan News
12.5 Exocell
12.5.1 Company Details
12.5.2 Glycated Albumin Product Offered
12.5.3 Exocell Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Exocell News
12.6 BSBE
12.6.1 Company Details
12.6.2 Glycated Albumin Product Offered
12.6.3 BSBE Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 BSBE News
12.7 Medicalsystem
12.7.1 Company Details
12.7.2 Glycated Albumin Product Offered
12.7.3 Medicalsystem Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Medicalsystem News
12.8 Maccura
12.8.1 Company Details
12.8.2 Glycated Albumin Product Offered
12.8.3 Maccura Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Maccura News
12.9 Leadman
12.9.1 Company Details
12.9.2 Glycated Albumin Product Offered
12.9.3 Leadman Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Leadman News
12.10 Simes Sikma
12.10.1 Company Details
12.10.2 Glycated Albumin Product Offered
12.10.3 Simes Sikma Glycated Albumin Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Simes Sikma News
12.11 NINGBO PUREBIO
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Glycated Albumin
Table Product Specifications of Glycated Albumin
Figure Glycated Albumin Report Years Considered
Figure Mark
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
